Localized competitions for systems
The new framework, which runs initially from 16 February 2015 through 15 February 2019, aims to provide Trusts and the wider public sector with a more agile and cost effective tendering process for their technology needs. NHS Providers can localize their requirements with 'mini-competitions' amongst approved suppliers, reducing the time and costs of procuring complex systems.
A total of 26 suppliers were selected, for six individual "lots" or product domains. Agfa HealthCare was selected for 5 of the "lots": Core Healthcare Clinical Information Systems, Integrated Emergency Care Systems, Theatre Systems, Maternity Systems and Electronic Prescribing Systems.
Powerful and flexible customization
For the selected suppliers, interoperability and integration of the systems was critical, as well as the ability of the Trusts to fine-tune the products and systems to their specific requirements.
"Our ORBIS integrated clinical and urgent care suite fits perfectly into the NHS SBS framework," comments Karen Middlehurst, Enterprise Business Unit Manager for Agfa HealthCare. "It is a comprehensive, proven solution with powerful and flexible customization features, and it supports medical, diagnostic and care workflows."
The ORBIS enterprise-wide IT solution is designed to provide fast availability of patients' histories, including images and clinical and administrative data. Its modular design lets each facility implement and evolve at its own pace, without disruption. The solution facilitates communication, collaboration, shared knowledge, documentation and work allocation between all team members.
Driving improvements in patient care
"This framework is about achieving a more efficient and strategic way of procuring complex clinical systems: it reduces the procurement timescales and saves tens of thousands of pounds in the process," explains Peter Akid, NHS SBS Director of Procurement. "We have ensured that NHS providers, including specialist clinicians, lead pharmacists and doctors, have been in the driving seat when it comes to defining the specifications and evaluating system functionality, to providethe framework is right for them. The framework has brought together a combination of suppliers who are in the best position to help providers reap the benefits of clinical information systems that can drive forward improvements in delivery of patient care."
"We are very proud that the NHS SBS recognize our ability to fulfil the strict criteria for the framework. Thousands of healthcare facilities all over the world already rely on Agfa HealthCare's IT solutions. This move will make it easier for Trusts and other public bodies to experience the patient care and decision-making benefits of our proven solutions," concludes Karen Middlehurst.
Related news articles:
- Agfa HealthCare's Profile
About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,865 million euro in 2013.
About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2013 were 1,160 million euro.